Evidence map›Paper›PMID 34323996›Full record

ArticleMolecular biology and evolution2021

Evolution of Renal-Disease Factor APOL1 Results in Cis and Trans Orientations at the Endoplasmic Reticulum That Both Show Cytotoxic Effects.

Daria Müller, Jürgen Schmitz, Katharina Fischer, Daniel Granado, Ann-Christin Groh, Vanessa Krausel, Simona Mareike Lüttgenau, Till Maximilian Amelung, Hermann Pavenstädt, Thomas Weide

Open access · goldAbstract read
In one paragraph

Article in Molecular biology and evolution, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Daria MüllerInternal Medicine D (MedD), Molecular Nephrology, University Hospital of Münster (UKM), Münster, Germany.
Jürgen SchmitzInstitute of Experimental Pathology, ZMBE, University of Münster, Münster, Germany.ORCID 0000-0002-4686-861X
Katharina FischerInternal Medicine D (MedD), Molecular Nephrology, University Hospital of Münster (UKM), Münster, Germany.
Daniel GranadoInternal Medicine D (MedD), Molecular Nephrology, University Hospital of Münster (UKM), Münster, Germany.
Ann-Christin GrohInternal Medicine D (MedD), Molecular Nephrology, University Hospital of Münster (UKM), Münster, Germany.
Vanessa KrauselInternal Medicine D (MedD), Molecular Nephrology, University Hospital of Münster (UKM), Münster, Germany.
Simona Mareike LüttgenauInternal Medicine D (MedD), Molecular Nephrology, University Hospital of Münster (UKM), Münster, Germany.
Till Maximilian AmelungInternal Medicine D (MedD), Molecular Nephrology, University Hospital of Münster (UKM), Münster, Germany.
Hermann PavenstädtInternal Medicine D (MedD), Molecular Nephrology, University Hospital of Münster (UKM), Münster, Germany.
Thomas WeideInternal Medicine D (MedD), Molecular Nephrology, University Hospital of Münster (UKM), Münster, Germany.
University Hospital Münster · DEUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent and exclusively in humans and a few other higher primates expressed APOL1 (apolipoprotein L1) gene is linked to African human trypanosomiasis (also known as African sleeping sickness) as well as to different forms of kidney diseases. Whereas APOL1's role as a trypanolytic factor is well established, pathobiological mechanisms explaining its cytotoxicity in renal cells remain unclear. In this study, we compared the APOL family members using a combination of evolutionary studies and cell biological experiments to detect unique features causal for APOL1 nephrotoxic effects. We investigated available primate and mouse genome and transcriptome data to apply comparative phylogenetic and maximum likelihood selection analyses. We suggest that the APOL gene family evolved early in vertebrates and initial splitting occurred in ancestral mammals. Diversification and differentiation of functional domains continued in primates, including developing the two members APOL1 and APOL2. Their close relationship could be diagnosed by sequence similarity and a shared ancestral insertion of an AluY transposable element. Live-cell imaging analyses showed that both expressed proteins show a strong preference to localize at the endoplasmic reticulum (ER). However, glycosylation and secretion assays revealed that-unlike APOL2-APOL1 membrane insertion or association occurs in different orientations at the ER, with the disease-associated mutants facing either the luminal (cis) or cytoplasmic (trans) side of the ER. The various pools of APOL1 at the ER offer a novel perspective in explaining the broad spectrum of its observed toxic effects.

Indexed as

Apolipoprotein L1Endoplasmic ReticulumAnimalsApolipoproteinsMammalsMicePhylogenyPrimatesApolipoprotein L1ApolipoproteinsAPOL1APOL2APOL gene family, APOL phylogeny, APOL selection analysesendoplasmic reticulumevolutionary medicinekidney disease

Identifiers

PMID34323996
PMCPMC8557400
OpenAlexW3183561286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.